AMGN

$347.84 -1.18% $-4.16
Jun 16, 2026 04:00 AM

AMGN stands for Amgen Inc., a leading biotechnology company focused on discovering, developing, and delivering innovative human therapeutics.

Scroll or pinch to zoom · drag to pan the chart

Updating chart…

Price chart bar size:

Share on:

Asset Summary

Loading summary…

Asset Performance Metrics and Risk Characteristics:

Metrics below use daily returns for Jan 1, 2026 – Jun 17, 2026 (YTD).

Understanding asset performance is crucial for evaluating investment quality and making informed decisions. Metrics like trailing return and drawdown provide insights into how an asset has performed over time, its volatility, and the efficiency of its returns relative to risk. Performance indicators help assess the stability, risk, and reward of an investment, allowing investors and portfolio managers to make comparisons and strategize accordingly.

Asset Technical Analysis

Technical analysis involves evaluating an asset's price and volume data to forecast future movements and make informed trading decisions. Using indicators such as moving averages, pivot levels, momentum studies, and candlestick pattern scans can clarify trend strength and volatility. The tabs below summarize moving averages, pivots, technical indicators, candlestick patterns, and recent prices for this symbol.

Analysis

Moving Averages

Moving Averages are commonly used to smooth out price data and identify trends over a specific period. Here’s a summary of the latest moving averages for various periods:

  • SMA (Simple Moving Average): Reflects the average price over a specific number of periods.
  • EMA (Exponential Moving Average): Gives more weight to recent prices, making it more responsive to new information.
  • WMA (Weighted Moving Average): Assigns a weight to each price, emphasizing more recent prices.
  • WEMA (Weighted Exponential Moving Average): Combines elements of both WMA and EMA for a more responsive moving average.

Maximize Your AMGN Trading Now

Revolutionize your investment in AMGN with OHLCX’s innovative trading solutions. Benefit from our comprehensive risk management features and sophisticated price analysis tools. Enhance your market performance today with OHLCX now and achieve better trading outcomes!

Explore Insights Now

Frequently Asked Questions

Amgen develops innovative medicines that address serious diseases, improving patient outcomes and enhancing the quality of life for patients globally.

Yes, AMGN can typically be included in retirement accounts such as IRAs or 401(k)s, depending on your brokerage options.

Amgen is recognized for its robust research pipeline, innovative therapies, and commitment to quality in biopharmaceuticals.

Risks include regulatory challenges, competition from generic drugs, and the volatility associated with biotechnology stocks.

Historically, AMGN has shown strong performance and resilience, reflecting the growth trends in the biotechnology sector.

Amgen reports its financial results on a quarterly and annual basis, offering insights into its earnings and business operations.

Amgen generates revenue primarily through the sale of its biologic drugs and therapies, as well as licensing agreements and partnerships with other companies.

Investing in AMGN may be attractive if you believe in the growth potential of the biotechnology sector, but potential investors should conduct thorough research.

Amgen’s key products include therapies for cancer, kidney disease, rheumatoid arthritis, and other serious medical conditions, such as Neulasta and Enbrel.

Amgen is headquartered in Thousand Oaks, California, USA.

Unleash Your AMGN Trading Now

Elevate your trading strategy with OHLCX execution platform’s sophisticated tools for AMGN. Our system integrates cutting-edge technology and expert analysis to support your investment goals. Boost your investment success with us and explore the benefits of advanced trading now!

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.

With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.

Market data is provided in near real-time when available, but we do not guarantee its accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.